Skip to Main Content

Paper Details

A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.
Sci Transl Med
108
2021
0129, Bcl2L12, Bcl2L12 protein, GBM, Glioblastoma, NU-, NU-0129, Patients, RNA, SNAs, cancers, glioma, glioma cells, human, macrophages, oncogene Bcl2Like12, patient, patients, recurrent glioblastoma, recurrent tumor, siRNA, silver, small interfering RNA, tumor, tumor cells, tumors
Author NameAffiliation
Priya KumthekarThe Northwestern Malnati Brain Tumor Institute, Feinberg School of Medicine, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Adam M SonabendFeinberg School of Medicine, Northwestern University
Orin BlochFeinberg School of Medicine, Northwestern University
Borko JovanovicFeinberg School of Medicine, Northwestern University
Kathleen McCortneyFeinberg School of Medicine, Northwestern University
Howard ColmanHuntsman Cancer Institute and Department of Neurosurgery, University of Utah
Howard ColmanHuntsman Cancer Institute and Department of Neurosurgery, University of Utah
Dusten UnruhFeinberg School of Medicine, Northwestern University
Manoj KandpalFeinberg School of Medicine, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Ramana V DavuluriFeinberg School of Medicine, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Daniel J BratFeinberg School of Medicine, Northwestern University
Charles D JamesFeinberg School of Medicine, Northwestern University
Craig HorbinskiFeinberg School of Medicine, Northwestern University
Craig HorbinskiFeinberg School of Medicine, Northwestern University
  • 1 - 14

Datasets

Release 1.2